Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Graham

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 10, 2000
Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic miceR S Peebles, R Dworski, R D Collins, et al.
Vaccine|April 1, 1997
Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccineK M Neuzil, J E Johnson, Y W Tang, et al.
The Journal of Clinical Investigation|May 1, 1993
Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccineesS H Pincus, K G Messer, D H Schwartz, et al.
Annals of Internal Medicine|October 15, 1994
Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials GroupR B Belshe, M L Clements, M C Keefer, et al.
Journal of Virology|October 29, 1997
Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virusJ E Fischer, J E Johnson, R K Kuli-Zade, et al.
Thorax|May 31, 2002
Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitorK Hashimoto, R S Peebles, J R Sheller, et al.
The Journal of Infectious Diseases|December 26, 2001
Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challengesR S Peebles, K Hashimoto, R D Collins, et al.
Journal of Clinical Microbiology|June 1, 1986
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infectionB R Murphy, B S Graham, G A Prince, et al.
Journal of Medical Virology|February 15, 2001
Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in miceR S Peebles, J R Sheller, R D Collins, et al.
The Journal of Clinical Investigation|August 1, 1993
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials NetworkD C Montefiori, B S Graham, J Zhou, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
American Journal of Respiratory and Critical Care Medicine|August 10, 2000
Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic miceR S Peebles, R Dworski, R D Collins, et al.
Vaccine|April 1, 1997
Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccineK M Neuzil, J E Johnson, Y W Tang, et al.
The Journal of Clinical Investigation|May 1, 1993
Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccineesS H Pincus, K G Messer, D H Schwartz, et al.
Annals of Internal Medicine|October 15, 1994
Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials GroupR B Belshe, M L Clements, M C Keefer, et al.
Journal of Virology|October 29, 1997
Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virusJ E Fischer, J E Johnson, R K Kuli-Zade, et al.
Thorax|May 31, 2002
Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitorK Hashimoto, R S Peebles, J R Sheller, et al.
The Journal of Infectious Diseases|December 26, 2001
Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challengesR S Peebles, K Hashimoto, R D Collins, et al.
Journal of Clinical Microbiology|June 1, 1986
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infectionB R Murphy, B S Graham, G A Prince, et al.
Journal of Medical Virology|February 15, 2001
Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in miceR S Peebles, J R Sheller, R D Collins, et al.
The Journal of Clinical Investigation|August 1, 1993
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials NetworkD C Montefiori, B S Graham, J Zhou, et al.
Pageof 14